{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T16:40:09Z","timestamp":1726418409617},"reference-count":15,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1016\/j.contraception.2005.07.016","type":"journal-article","created":{"date-parts":[[2005,10,20]],"date-time":"2005-10-20T14:20:30Z","timestamp":1129818030000},"page":"261-264","source":"Crossref","is-referenced-by-count":2,"title":["Mifepristone vaginally in an early medical abortion regimen: a pilot study"],"prefix":"10.1016","volume":"73","author":[{"given":"Sunita","family":"Sharma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hazem","family":"El-Refaey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Mitchel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozkan","family":"Ozturk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Rodeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2005.07.016_bib1","first-page":"CD002855","article-title":"Medical methods for first trimester abortion","author":"Kulier","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.contraception.2005.07.016_bib2","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1001\/jama.284.15.1948","article-title":"Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion: a randomized trial","volume":"284","author":"Schaff","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.contraception.2005.07.016_bib3","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/01.AOG.0000124271.23499.84","article-title":"A randomized comparison of misoprostol 6 to 8 hours versus 24 hours after mifepristone for abortion","volume":"103","author":"Creinin","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2005.07.016_bib4","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1749-6632.1997.tb48550.x","article-title":"The first uterine pass effect","volume":"828","author":"De Ziegler","year":"1997","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.contraception.2005.07.016_bib5","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/humupd\/6.2.139","article-title":"Comparison between different routes of progesterone administration as luteal phase support in infertility treatments","volume":"6","author":"Tavaniotou","year":"2000","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.contraception.2005.07.016_bib6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0010-7824(94)90085-X","article-title":"Early induction of abortion by a combination of oral mifepristone and misoprostol administered by the vaginal route","volume":"49","author":"el Refaey","year":"1994","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2005.07.016_bib7","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0002-9378(12)90877-7","article-title":"The reliability of ultrasonography in the management of spontaneous abortion, clinically thought to be complete: a prospective study","volume":"168","author":"Rulin","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2005.07.016_bib8","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1001\/jama.272.15.1190","article-title":"Methotrexate and misoprostol vs misoprostol alone for early abortion. A randomized controlled trial","volume":"272","author":"Creinin","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.contraception.2005.07.016_bib9","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3109\/13625189709167474","article-title":"The use of misoprostol for abortion at < or = 9 weeks' gestation","volume":"2","author":"Carbonell","year":"1997","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2005.07.016_bib10","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0010-7824(97)00020-6","article-title":"The use of misoprostol for termination of early pregnancy","volume":"55","author":"Carbonell","year":"1997","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2005.07.016_bib11","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/S0002-9378(99)70380-7","article-title":"Early pregnancy termination with intravaginally administered sodium chloride solution-moistened misoprostol tablets: historical comparison with mifepristone and oral misoprostol","volume":"181","author":"Jain","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2005.07.016_bib12","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0169-409X(93)90031-X","article-title":"Novel vaginal drug release applications","volume":"11","author":"Brannon-Peppas","year":"1993","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.contraception.2005.07.016_bib13","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0015-0282(16)48748-0","article-title":"Pregnancy prevention by intravaginal delivery of a progesterone antagonist: RU486 tampon for menstrual induction and absorption","volume":"44","author":"Hodgen","year":"1985","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2005.07.016_bib14","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/oxfordjournals.humrep.a136608","article-title":"Intravaginal administration of RU 486 in humans and rats: inadequate absorption in humans","volume":"2","author":"Heikinheimo","year":"1987","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2005.07.016_bib15","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0015-0282(16)56935-0","article-title":"Pharmacokinetics and endometrial tissue levels of progesterone after administration by intramuscular and vaginal routes: a comparative study","volume":"62","author":"Miles","year":"1994","journal-title":"Fertil Steril"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782405003070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782405003070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,2]],"date-time":"2019-04-02T02:49:42Z","timestamp":1554173382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782405003070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S0010782405003070"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2005.07.016","relation":{},"ISSN":["0010-7824"],"issn-type":[{"type":"print","value":"0010-7824"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}